TrialClinical pharmacology in drug development2023

Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration-QTc Analysis.

Frank Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.